Tag: Dry AMD
Eyestem completes first set of patient injections for its pioneering Dry...
Eyecyte-RPE™ is a patented suspension of retinal pigment epithelium cells aimed at combating geographic atrophy arising from Dry AMD
Eyestem Research moves one step closer to finding a treatment for...
Bengaluru-based biotechnology company announces successful animal experiments for its flagship product for Dry AMD, the largest cause of incurable blindness for people over 50 and affects nearly 170 million people worldwide
Endiya Partners invest in cell therapy company, Eyestem
The company is poised to become one of the first companies in the world to develop a treatment for Dry AMD (Age-related Macular Degeneration), the largest cause of incurable blindness that affects nearly 170 million people worldwide...........................